Product Recalls in Arkansas

Product recalls affecting Arkansas — including food, drugs, consumer products, medical devices, and vehicles distributed to Arkansas. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,662 recalls have been distributed to Arkansas in the last 12 months.

49,990 total recalls
2,662 in last 12 months

Showing 661680 of 13,434 recalls

DrugMarch 4, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Gabapentin Capsules Recalled by SUN PHARMACEUTICAL INDUSTRIES INC Due to...

The Issue: Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 4, 2025· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Gabapentin Capsules Recalled by SUN PHARMACEUTICAL INDUSTRIES INC Due to...

The Issue: Cross Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 4, 2025· The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Recalled Item: Tolterodine Tartrate Extended-Release Capsules Recalled by The Harvard Drug...

The Issue: Failed Dissolution Specifications: Out of specification results obtained...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMarch 4, 2025· Chattem Inc

Recalled Item: Unisom Recalled by Chattem Inc Due to CGMP Deviations: Nitrosamine Drug...

The Issue: CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets USP 25 mg Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets USP 12.5 mg Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets USP 3.125mg Tablets a.)100-count bottle (NDC...

The Issue: CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets USP 6.25 mg Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations; presence 'N-Nitroso Carvedilol I' Impurity above the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2025· Breckenridge Pharmaceutical, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules Recalled by Breckenridge Pharmaceutical,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 28, 2025· Sigan Industries Group Inc.

Recalled Item: Walgreens Recalled by Sigan Industries Group Inc. Due to Chemical...

The Issue: Chemical Contamination: Presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 27, 2025· Amgen, Inc.

Recalled Item: Neupogen (filgrastim) For Injection Recalled by Amgen, Inc. Due to Stability...

The Issue: Stability data does not support expiry: the products have the potential to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 27, 2025· Amgen, Inc.

Recalled Item: Neupogen (filgrastim) For Injection Recalled by Amgen, Inc. Due to Stability...

The Issue: Stability data does not support expiry: the products have the potential to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 25, 2025· A-S Medication Solutions LLC

Recalled Item: METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG Recalled by A-S Medication...

The Issue: Presence of Foreign Tablets/Capsules.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 25, 2025· MYLAN PHARMACEUTICALS INC

Recalled Item: Prasugrel Tablets Recalled by MYLAN PHARMACEUTICALS INC Due to Failed...

The Issue: Failed Dissolution Specifications - low dissolution results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 24, 2025· Denison Pharmaceuticals, LLC

Recalled Item: Zapzyt Recalled by Denison Pharmaceuticals, LLC Due to Chemical...

The Issue: Chemical Contamination: Presence of benzene.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 20, 2025· One Source Nutrition, Inc,

Recalled Item: Vitality Recalled by One Source Nutrition, Inc, Due to Undeclared Sildenafil

The Issue: Marketed without an approved NDA/ANDA: Product found to be tainted with...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 20, 2025· Central Admixture Pharmacy Services, Inc.

Recalled Item: PHENYLephrine added to 0.9% sodium chloride Recalled by Central Admixture...

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugFebruary 18, 2025· Turbare Manufacturing

Recalled Item: Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe Recalled by Turbare Manufacturing...

The Issue: Lack of Assurance of Sterility: due to a quality control process deviation....

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund